Funding
FY2025 Go-Tech research and development grant · Biotech

Revascular Bio selected for Japan’s Go-Tech R&D subsidy

The support adds to the company’s research into vascular endothelial stem-cell therapies.

By RoundOS Funding desk

Revascular Bio Co., Ltd. has been selected for Japan’s FY2025 Go-Tech research and development subsidy programme, the company announced on June 30, 2025. Its award amount was not disclosed.

The company plans to use the support to accelerate research and development. It develops cell therapies using vascular endothelial stem cells, with programmes including difficult-to-treat skin ulcers and haemophilia.

Use of funds

Advance research and development under the FY2025 Go-Tech programme

Funding history

FY2025 Go-Tech research and development grant · This roundUndisclosed
FY2024 second MU-TECH research grant¥3MAMED drug-discovery ecosystem grantUndisclosedOUVC2 investment¥220M

Sources

  1. Revascular Bio Go-Tech selectionrevascularbio.com · Jun 30, 2025

Similar rounds

All Biotech rounds →
ALLOX

ALLOX combines high-throughput genetics, experimental biology and AI to find functional sites on proteins and develop targeted small-molecule medicines.

$10.5MSeed · Oct 29, 2026
Dren Bio

Dren Bio develops antibody therapies for cancer, autoimmune conditions and other serious diseases.

$350MPrivate financing · Oct 29, 2026
BioGeometry

BioGeometry develops generative AI models and experimental workflows for protein design, drug discovery and enzyme engineering.

UndisclosedSeries A+ · Oct 28, 2026
IntegriCulture

IntegriCulture develops cell-culture systems and production technology for cellular foods, cosmetics and other biological materials.

UndisclosedFunding round · Oct 28, 2026

Related